Artivion (AORT) Tops Q2 EPS by 12c; Offers FY23 Revenue Guidance

Artivion (NYSE: AORT) reported Q2 EPS of $0.06, $0.12 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $89.3 million versus the consensus estimate of $84.24 million.

GUIDANCE:

Artivion sees FY2023 revenue of $342-350 million, versus the consensus of $340.7 million.

For earnings history and earnings-related data on Artivion (AORT) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
• EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance